Tailor-made Pharma Solutions l Pharma Intelligence

Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Commercial Success

Clinical Planning

Patient Engagement & Recruitment

Regulatory & Compliance

Conferences 2022

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Tailor-made solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

A customized approach – we develop solutions to fit your situation
Joint problem/opportunity definition
Proprietary data and complementary market research
The experience of 500+ industry experts
Collaborative problem solving
Fact-based decisions and actionable recommendations
Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

Citeline Study Feasibility

Bio-IT World Conference & Expo

30 Jul 2022

Full podcast
Citeline

Integrate your data to get the full picture

28 Jul 2022

View article
Biomedtracker

Biomedtracker 2018 Early Outlook Report

28 Jul 2022

What's on the horizon for pharma in 2018? Find out with Biomedtracker's Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

Topic Drug Development Landscape

Single report
Datamonitor Healthcare

Profitability Assessment of Branded Generic Inhalers

By Ljlal Syed, Mark Lansdell and David Abramson 28 Jul 2022

This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic

Topic Deals

Single report
Datamonitor Healthcare

Immuno-Oncology Overview

By Colin White, Robert Jeng & Jolene Lau 28 Jul 2022

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well

Topic immuno-oncology

Single report
Trialtrove

Expanded Curation of Immuno-Oncology Combination Trials in Trialtrove

01 Jul 2022

To highlight the growing importance of IO and especially IO combination trials within oncology clinical development, visual trends and key insights about the past 20+ years were compiled.

View article
Citeline

Pharma R&D Annual Review 2022 Supplement: New Active Substances Launched During 2021

27 Jun 2022

Following on from our review of trends in the current pharmaceutical R&D pipeline, this supplement takes a look at the industry’s success stories of 2021 – the drugs which were launched onto the market for the first time during the year.

View white paper
Citeline

Pharma R&D Annual Review 2022: Navigating the Landscape

27 Jun 2022

Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.

View white paper
Citeline

2021 Completed Trials: Green Shoots of COVID-19 Recovery Become Apparent

27 Jun 2022

As the COVID-19 pandemic stretched through a second year, its impacts continued to reshape the clinical trials landscape.

Topic Clinical Trials

View white paper
Citeline

Measuring the COVID Effect on Clinical Trials

27 Jun 2022

As the world begins its transition into a post-pandemic existence, it becomes possible to look back on the past two years and begin to quantify the effects that COVID-19 has brought.

Topic Clinical Trials

View white paper
Biomedtracker

Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets

By Dominique Fontanilla 20 Jun 2022

Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets".

Topic Drug Development Landscape

Full video
Datamonitor Healthcare

Webinar: Manufacturing Challenges Facing Cell and Gene Therapy

By Amanda Micklus 20 Jun 2022

As more regenerative medicine products approach clinical testing and commercialization, seize this opportunity to hear detailed insights and industry best practices from preeminent sector experts. You’ll gain a deep understanding of numerous nurdles unique to bringing durable, curative therapies to patients in need.

Topic Cell & Gene Therapy

Full video
Scrip

Get your FREE extract of the 2021 Scrip Asia 100 Report Now | Pharma Intelligence

17 Jun 2022

As we continue to navigate unprecedented times, the pharma industry in the Asia Pacific region has been persistently moving forward with clinical trial advancements.

Topic Business Strategies

Single report
Meddevicetracker

Robotic Surgery 4.0 Innovative Robotic Assisted Systems & their Applications

17 Jun 2022

The webinar will provide a thought leadership perspective on the key challenges and trends in the emerging Robotic Surgery market.

Full webinar
Pharma R&D Annual Review 2018

Ian Lloyd 17 Jun 2022

Authored for the last 25 years by Ian Lloyd, Senior Director of Pharmaprojects and Data Integration, this vital resource uses a music motif to turn up the volume on the evolution of trends in pharmaceutical R&D. Lloyd assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.

Research & Development

View white paper

Latest headlines

Pink Sheet

26 Jul 2022

Vaginal Yeast Infections Are A Bright Spot For Anti-Infective Development

Link
Pink Sheet

26 Jul 2022

More Action, Less Plan? House Keeps Pressure On US FDA Over ALS Drugs

Link
Generics Bulletin

26 Jul 2022

Australian Industry Working To Minimize Medicines Shortages

Link
Generics Bulletin

26 Jul 2022

Teva Fails On Quillivant XR Appeal – Five Years After Winning

Link
Scrip

26 Jul 2022

Idorsia’s Quviviq Needs To Rise And Shine After Slow Launch

Link
Pink Sheet

26 Jul 2022

Global Regulators Join Hands To Boost RWE Use In Decision-Making

Link
Medtech Insight

26 Jul 2022

The Good And Bad News When It Comes To EU Notified Bodies’ Designation Capacity

Link
Medtech Insight

26 Jul 2022

Exo Acquires Medo To Add Sweep AI To Its POCUS Tech

Link
Pink Sheet

26 Jul 2022

China Clears HIV Oral Antiviral For COVID, Vows More Drug Approvals

Link
Scrip

26 Jul 2022

'No Future Without New Drugs': Yuhan CSO On Open Innovation Strategy

Link
HBW Insight

26 Jul 2022

Coppertone Facial Sunscreen Is Repackaged Body Lotion At Higher Price – Proposed Class Action

Link
Medtech Insight

26 Jul 2022

Biotronik Pays Almost $13M To Resolve Physician Kickback Allegations

Link
Scrip

26 Jul 2022

AstraZeneca’s Triple Regulatory Wins For Enhertu, Tezspire And Ultomiris Herald Sales Boost

Link
Medtech Insight

26 Jul 2022

Minute Insight: Are Things Going Pear-Shaped For Digital Therapeutics?

Link
Pink Sheet

26 Jul 2022

Straightforward But Technical: Transferring Existing Studies To EU Clinical Trial Portal

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Speak to Sales

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact Sales

Client Services

US Toll-Free : +1 888 670 8900
US Toll : +1 212-600-3520
UK & Europe : +44 (0) 208 052 0700

Contact Customer Services

Pharma Report Store

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now

Tailor-made Pharma Solutions

Tailor-made solutions

Pharma Intelligence latest insights

Bio-IT World Conference & Expo

Integrate your data to get the full picture

Biomedtracker 2018 Early Outlook Report

Profitability Assessment of Branded Generic Inhalers

Immuno-Oncology Overview

Expanded Curation of Immuno-Oncology Combination Trials in Trialtrove

Pharma R&D Annual Review 2022 Supplement: New Active Substances Launched During 2021

Pharma R&D Annual Review 2022: Navigating the Landscape

2021 Completed Trials: Green Shoots of COVID-19 Recovery Become Apparent

Measuring the COVID Effect on Clinical Trials

Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets

Webinar: Manufacturing Challenges Facing Cell and Gene Therapy

Get your FREE extract of the 2021 Scrip Asia 100 Report Now | Pharma Intelligence

Robotic Surgery 4.0 Innovative Robotic Assisted Systems & their Applications

Pharma R&D Annual Review 2018

Latest headlines

Vaginal Yeast Infections Are A Bright Spot For Anti-Infective Development

More Action, Less Plan? House Keeps Pressure On US FDA Over ALS Drugs

Australian Industry Working To Minimize Medicines Shortages

Teva Fails On Quillivant XR Appeal – Five Years After Winning

Idorsia’s Quviviq Needs To Rise And Shine After Slow Launch

Global Regulators Join Hands To Boost RWE Use In Decision-Making

The Good And Bad News When It Comes To EU Notified Bodies’ Designation Capacity

Exo Acquires Medo To Add Sweep AI To Its POCUS Tech

China Clears HIV Oral Antiviral For COVID, Vows More Drug Approvals

'No Future Without New Drugs': Yuhan CSO On Open Innovation Strategy

Coppertone Facial Sunscreen Is Repackaged Body Lotion At Higher Price – Proposed Class Action

Biotronik Pays Almost $13M To Resolve Physician Kickback Allegations

AstraZeneca’s Triple Regulatory Wins For Enhertu, Tezspire And Ultomiris Herald Sales Boost

Minute Insight: Are Things Going Pear-Shaped For Digital Therapeutics?

Straightforward But Technical: Transferring Existing Studies To EU Clinical Trial Portal

Next steps

This is Contactus Section

Request a live demo

Speak to Sales

Client Services

Pharma Report Store